Identification of rare genetic variants in novel loci associated with Paget’s disease of bone
详细信息 查看全文
- 作者：Mariejka Beauregard (1) (2)
Edith Gagnon (1)
Sabrina Guay-Bélanger (1) (2)
Jean Morissette (1)
Jacques P. Brown (1) (2) (3)
La?titia Michou (1) (2) (3) - 刊名：Human Genetics
- 出版年：2014
- 出版时间：June 2014
- 年：2014
- 卷：133
- 期：6
- 页码：755-768
- 全文大小：
- 参考文献：1. Albagha OM, Visconti MR, Alonso N, Langston AL, Cundy T, Dargie R, Dunlop MG, Fraser WD, Hooper MJ, Isaia G, Nicholson GC, del Pino Montes J, Gonzalez-Sarmiento R, di Stefano M, Tenesa A, Walsh JP, Ralston SH (2010) Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget’s disease of bone. Nat Genet 42:520-24 (pii:ng.562) CrossRef
2. Albagha OM, Wani SE, Visconti MR, Alonso N, Goodman K, Brandi ML, Cundy T, Chung PY, Dargie R, Devogelaer JP, Falchetti A, Fraser WD, Gennari L, Gianfrancesco F, Hooper MJ, Van Hul W, Isaia G, Nicholson GC, Nuti R, Papapoulos S, Montes Jdel P, Ratajczak T, Rea SL, Rendina D, Gonzalez-Sarmiento R, Di Stefano M, Ward LC, Walsh JP, Ralston SH (2011) Genome-wide association identifies three new susceptibility loci for Paget’s disease of bone. Nat Genet 43:685-89 (pii:ng.845) CrossRef
3. Asimit J, Zeggini E (2009) Testing for rare variant associations in complex diseases. Genome Med 1:24. doi:10.1186/gm238 CrossRef
4. Bodmer W, Bonilla C (2008) Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40:695-01 (pii:ng.f.136) CrossRef
5. Bodmer W, Tomlinson I (2010) Rare genetic variants and the risk of cancer. Curr Opin Genet Dev 20:262-67. doi:10.1016/j.gde.2010.04.016 CrossRef
6. Cirulli ET, Goldstein DB (2010) Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 11:415-25. doi:10.1038/nrg2779 CrossRef
7. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH (2004) Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305:869-72. doi:10.1126/science.1099870 CrossRef
8. Frazer KA, Murray SS, Schork NJ, Topol EJ (2009) Human genetic variation and its contribution to complex traits. Nat Rev Genet 10:241-51. doi:10.1038/nrg2554 CrossRef
9. Gibson G (2011) Rare and common variants: twenty arguments. Nat Rev Genet 13:135-45. doi:10.1038/nrg3118 CrossRef
10. Gorlov IP, Gorlova OY, Sunyaev SR, Spitz MR, Amos CI (2008) Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet 82:100-12. doi:10.1016/j.ajhg.2007.09.006 CrossRef
11. Haldane JB (1956) The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20:309-11 CrossRef
12. Hartgers FC, Vissers JL, Looman MW, van Zoelen C, Huffine C, Figdor CG, Adema GJ (2000) DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells. Eur J Immunol 30:3585-590. doi:10.1002/1521-4141(200012)30:12<3585:AID-IMMU3585>3.0.CO;2-Y CrossRef
13. Hershberger RE, Parks SB, Kushner JD, Li D, Ludwigsen S, Jakobs P, Nauman D, Burgess D, Partain J, Litt M (2008) Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clin Transl Sci 1:21-6. doi:10.1111/j.1752-8062.2008.00017.x CrossRef
14. Hershberger RE, Norton N, Morales A, Li D, Siegfried JD, Gonzalez-Quintana J (2010) Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circ Cardiovasc Genet 3:155-61. doi:10.1161/CIRCGENETICS.109.912345 CrossRef
15. Iascone M, Ciccone R, Galletti L, Marchetti D, Seddio F, Lincesso AR, Pezzoli L, Vetro A, Barachetti D, Boni L, Federici D, Soto AM, Comas JV, Ferrazzi P, Zuffardi O (2012) Identification of de novo mutations and rare variants in hypoplastic left heart syndrome. Clin Genet 81:542-54. doi:10.1111/j.1399-0004.2011.01674.x CrossRef
16. Kent JW, Farook V, G?ring HHH, Dyer TD, Almasy L, Duggirala R, Blangero J (2011) Do rare variant genotypes predict common variant genotypes? In: BMC Proceedings, p S87
17. Kimura H, Kwan KM, Zhang Z, Deng JM, Darnay BG, Behringer RR, Nakamura T, de Crombrugghe B, Akiyama H (2008) Cthrc1 is a positive regulator of osteoblastic bone formation. PLoS One 3:e3174. doi:10.1371/journal.pone.0003174 CrossRef
18. Laroche M, Delmotte A (2005) Increased arterial calcification in Paget’s disease of bone. Calcif Tissue Int 77:129-33. doi:10.1007/s00223-005-0250-1 CrossRef
19. Lathrop GM, Lalouel JM (1984) Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet 36:460-65
20. LeClair RJ, Durmus T, Wang Q, Pyagay P, Terzic A, Lindner V (2007) Cthrc1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation. Circ Res 100:826-33. doi:10.1161/01.RES.0000260806.99307.72 CrossRef
21. Li WF, Hou SX, Ferec C, Chen JM (2011) Osteoporosis: Genetics. Encyclopedia of Life Sciences (ELS). Wiley, Chichester. doi:10.1002/9780470015902.a0022925
22. Lusis AJ, Pajukanta P (2008) A treasure trove for lipoprotein biology. Nat Genet 40:129-30. doi:10.1038/ng0208-129 CrossRef
23. Lyles KW, Siris ES, Singer FR, Meunier PJ (2001) A clinical approach to diagnosis and management of Paget’s disease of bone. J Bone Miner Res 16:1379-387. doi:10.1359/jbmr.2001.16.8.1379 CrossRef
24. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, Visscher PM (2009) Finding the missing heritability of complex diseases. Nature 461:747-53. doi:10.1038/nature08494 CrossRef
25. Marian AJ (2012) Molecular genetic studies of complex phenotypes. Transl Res 159:64-9. doi:10.1016/j.trsl.2011.08.001 CrossRef
26. Mendes AI, Mascarenhas MR, Matos S, Sousa I, Ferreira J, Barbosa AP, Bicho M, Jordan P (2011) A WNK4 gene variant relates to osteoporosis and not to hypertension in the Portuguese population. Mol Genet Metab 102:465-69. doi:10.1016/j.ymgme.2010.12.010 CrossRef
27. Mensah KA, Ritchlin CT, Schwarz EM (2010) RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens. J Cell Physiol 223:76-3. doi:10.1002/jcp.22012
28. Miyamoto T (2011) Regulators of osteoclast differentiation and cell-cell fusion. Keio J Med 60:101-05 CrossRef
29. Morales-Piga AA, Rey-Rey JS, Corres-Gonzalez J, Garcia-Sagredo JM, Lopez-Abente G (1995) Frequency and characteristics of familial aggregation of Paget’s disease of bone. J Bone Miner Res 10:663-70 CrossRef
30. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA (2009) Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324:387-89. doi:10.1126/science.1167728 CrossRef
31. Pyagay P, Heroult M, Wang Q, Lehnert W, Belden J, Liaw L, Friesel RE, Lindner V (2005) Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. Circ Res 96:261-68. doi:10.1161/01.RES.0000154262.07264.12 CrossRef
32. Roodman GD, Windle JJ (2005) Paget disease of bone. J Clin Invest 115:200-08 CrossRef
33. Singer FR, Mills BG, Gruber HE, Windle JJ, Roodman GD (2006) Ultrastructure of bone cells in Paget’s disease of bone. J Bone Miner Res 21(Suppl 2):P51–P54. doi:10.1359/jbmr.06s209 CrossRef
34. Siris ES, Ottman R, Flaster E, Kelsey JL (1991) Familial aggregation of Paget’s disease of bone. J Bone Miner Res 6:495-00 CrossRef
35. Staden R (1996) The Staden sequence analysis package. Mol Biotechnol 5:233-41 CrossRef
36. Strickberger SA, Schulman SP, Hutchins GM (1987) Association of Paget’s disease of bone with calcific aortic valve disease. Am J Med 82:953-56 CrossRef
37. Wright T, Rea SL, Goode A, Bennett AJ, Ratajczak T, Long JE, Searle MS, Goldring CE, Park BK, Copple IM, Layfield R (2013) The S349T mutation of SQSTM1 links Keap1/Nrf2 signalling to Paget’s disease of bone. Bone 52:699-06. doi:10.1016/j.bone.2012.10.023 CrossRef
38. Xing Y, Niu T, Wang W, Li J, Li S, Janicki JS, Ruiz S, Meyer CJ, Wang XL, Tang D, Zhao Y, Cui T (2012) Triterpenoid dihydro-CDDO-trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2. PLoS One 7:e44899. doi:10.1371/journal.pone.0044899 CrossRef
39. Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, Fujita N, Morita K, Ninomiya K, Suzuki T, Miyamoto K, Oike Y, Takeya M, Toyama Y, Suda T (2005) DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202:345-51. doi:10.1084/jem.20050645 CrossRef
40. Yan Jenny Chung P, Van Hul W (2011) Paget’s disease of bone: evidence for complex pathogenetic interactions. Semin Arthritis Rheum. (pii:S0049-0172(11)00199-5)
41. Zhang J (2000) Rates of conservative and radical nonsynonymous nucleotide substitutions in mammalian nuclear genes. J Mol Evol 50:56-8 - 作者单位：Mariejka Beauregard (1) (2)
Edith Gagnon (1)
Sabrina Guay-Bélanger (1) (2)
Jean Morissette (1)
Jacques P. Brown (1) (2) (3)
La?titia Michou (1) (2) (3)
1. CHU de Québec Research Centre, Quebec, QC, Canada
2. Division of Rheumatology, Department of Medicine, Laval University, Quebec, QC, Canada
3. Department of Rhumatologie-S763, CHU de Québec, 2705 boulevard Laurier, Quebec, QC, G1V 4G2, Canada - ISSN：1432-1203
文摘
In genome-wide association studies, single nucleotide polymorphisms located in five novel loci were associated with PDB. We aimed at identifying rare genetic variants of candidate genes located in these loci and search for genetic association with PDB in the French-Canadian population. Exons, promoter and exon–intron junctions from patients with familial PDB and healthy individuals were sequenced in candidate genes, located within novel loci associated with PDB in our population. Rare variant was defined by a minor allele frequency <0.05 or absent from dbSNP (NCBI). We sequenced seven genes in 1p13 locus, three genes in 7q33, three genes in 8q22, and five genes in 15q24 locus. We identified 126 rare variants in at least one patient with PDB of whom 55 were located in 1p13 locus, 32 in 7q33, 10 in 8q22 and 29 in 15q24 locus. We located 71 of these 126 rare variants in an intron, 30 in an exon and 9 in an untranslated region. 60?% of these variants were located in functionally relevant gene regions. Among the 12 missense rare variants in PDB, two (rs62620995 in TM7SF4; rs62641691 in CD276) were predicted to be damaging by in silico analysis tools. Rs62620995, which altered a conserved amino acid (p.Leu397Phe) in the TM7SF4 gene, encoding the DC-STAMP protein involved in osteoclastogenesis through RANK signaling pathway, was found to have a marginal association with PDB (p?=?0.09). Rs35500845, located in the CTHRC1 gene, which encodes a regulator of collagen matrix deposition, was also associated with PDB in the French-Canadian population (p?=?0.046).